Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
31.14
-0.25 (-0.80%)
Apr 20, 2026, 11:33 AM EDT - Market open
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $3.09 billion as of April 20, 2026. Its market cap has increased by 72.06% in one year.
Market Cap
3.09B
Enterprise Value
1.99B
1-Year Change
72.06%
Ranking
Category
Stock Price
$31.14
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $3.09B, an increase of 842.94%. That is a compound annual growth rate of 43.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.12B | 13.95% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyne Therapeutics | 3.37B |
| Denali Therapeutics | 3.26B |
| Catalyst Pharmaceuticals | 3.21B |
| Alumis | 3.18B |
| Arcutis Biotherapeutics | 3.04B |
| Arcus Biosciences | 3.04B |
| Vera Therapeutics | 3.03B |
| Relay Therapeutics | 3.00B |